Published in JAMA on July 12, 2016
Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med (2011) 69.36
Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med (2005) 42.71
Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet (2007) 38.98
Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet (2007) 37.69
Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet (2010) 16.90
High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science (2013) 8.24
Defeating AIDS--advancing global health. Lancet (2015) 4.56
Failure of immunologic criteria to appropriately identify antiretroviral treatment failure in Uganda. AIDS (2009) 4.54
HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med (2012) 4.08
Male circumcision for HIV prevention in high HIV prevalence settings: what can mathematical modelling contribute to informed decision making? PLoS Med (2009) 4.05
A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda. AIDS (1998) 3.54
Model-checking techniques based on cumulative residuals. Biometrics (2002) 2.58
Assessing Progress, Impact, and Next Steps in Rolling Out Voluntary Medical Male Circumcision for HIV Prevention in 14 Priority Countries in Eastern and Southern Africa through 2014. PLoS One (2016) 2.50
HIV-1 target cells in foreskins of African men with varying histories of sexually transmitted infections. Am J Clin Pathol (2006) 2.10
Foreskin surface area and HIV acquisition in Rakai, Uganda (size matters). AIDS (2009) 2.01
Association of the ANRS-12126 male circumcision project with HIV levels among men in a South African township: evaluation of effectiveness using cross-sectional surveys. PLoS Med (2013) 1.78
Engaging men in prevention and care for HIV/AIDS in Africa. PLoS Med (2012) 1.71
HIV treatment as prevention: the utility and limitations of ecological observation. PLoS Med (2012) 1.55
Economics of antiretroviral treatment vs. circumcision for HIV prevention. Proc Natl Acad Sci U S A (2012) 1.54
The role of viral introductions in sustaining community-based HIV epidemics in rural Uganda: evidence from spatial clustering, phylogenetics, and egocentric transmission models. PLoS Med (2014) 1.43
Non-enrollment for free community HIV care: findings from a population-based study in Rakai, Uganda. AIDS Care (2011) 1.30
Foreskin inflammation is associated with HIV and herpes simplex virus type-2 infections in Rakai, Uganda. AIDS (2009) 1.21
The accuracy of women's reports of their partner's male circumcision status in Rakai, Uganda. AIDS (2013) 0.84
Participation dynamics in population-based longitudinal HIV surveillance in rural South Africa. PLoS One (2015) 0.83
A 15-year study of the impact of community antiretroviral therapy coverage on HIV incidence in Kenyan female sex workers. AIDS (2015) 0.83
The safety of adult male circumcision in HIV-infected and uninfected men in Rakai, Uganda. PLoS Med (2008) 2.79
The safety and acceptance of the PrePex device for non-surgical adult male circumcision in Rakai, Uganda. A non-randomized observational study. PLoS One (2014) 1.54
Use of injectable hormonal contraception and women's risk of herpes simplex virus type 2 acquisition: a prospective study of couples in Rakai, Uganda. Lancet Glob Health (2015) 1.46
Male circumcision wound healing in human immunodeficiency virus (HIV)-negative and HIV-positive men in Rakai, Uganda. BJU Int (2013) 1.45
HIV shedding from male circumcision wounds in HIV-infected men: a prospective cohort study. PLoS Med (2015) 0.95
Genital Anaerobic Bacterial Overgrowth and the PrePex Male Circumcision Device, Rakai, Uganda. J Infect Dis (2016) 0.88
Penile Microbiota and Female Partner Bacterial Vaginosis in Rakai, Uganda. MBio (2015) 0.86
High-risk human papillomavirus viral load and persistence among heterosexual HIV-negative and HIV-positive men. Sex Transm Infect (2014) 0.85
Heterogeneity of the HIV epidemic in agrarian, trading, and fishing communities in Rakai, Uganda: an observational epidemiological study. Lancet HIV (2016) 0.84
Decreased monocyte activation with daily acyclovir use in HIV-1/HSV-2 coinfected women. Sex Transm Infect (2015) 0.81
A transmission-virulence evolutionary trade-off explains attenuation of HIV-1 in Uganda. Elife (2016) 0.81
Safety of medical male circumcision in human immunodeficiency virus-infected men in Rakai, Uganda. Urology (2013) 0.77
Cerebrospinal fluid biomarkers and HIV-associated neurocognitive disorders in HIV-infected individuals in Rakai, Uganda. J Neurovirol (2016) 0.76
HIV policy implementation in two health and demographic surveillance sites in Uganda: findings from a national policy review, health facility surveys and key informant interviews. Implement Sci (2017) 0.75
Effects of medical male circumcision (MC) on plasma HIV viral load in HIV+ HAART naïve men; Rakai, Uganda. PLoS One (2014) 0.75
The Incidence Patterns Model to Estimate the Distribution of New HIV Infections in Sub-Saharan Africa: Development and Validation of a Mathematical Model. PLoS Med (2016) 0.75
Hepatitis E virus seroprevalence and correlates of anti-HEV IgG antibodies in the Rakai District, Uganda. J Infect Dis (2017) 0.75
Penile Anaerobic Dysbiosis as a Risk Factor for HIV Infection. MBio (2017) 0.75
Penile Immune Activation and Risk of HIV Shedding: A Prospective Cohort Study. Clin Infect Dis (2016) 0.75
The validity of self-reported antiretroviral use in persons living with HIV: a population-based study. AIDS (2017) 0.75